Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Total Current Liabilities: 2011-2019

Historic Total Current Liabilities for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Mar 2019 value amounting to $24.7 million.

  • EyePoint Pharmaceuticals' Total Current Liabilities rose 16.23% to $24.7 million in Q1 2019 from the same period last year, while for Mar 2019 it was $24.7 million, marking a year-over-year increase of 16.23%. This contributed to the annual value of $21.7 million for FY2018, which is 309.51% up from last year.
  • Per EyePoint Pharmaceuticals' latest filing, its Total Current Liabilities stood at $24.7 million for Q1 2019, which was up 14.91% from $21.5 million recorded in Q4 2018.
  • EyePoint Pharmaceuticals' 5-year Total Current Liabilities high stood at $24.7 million for Q1 2019, and its period low was $2.2 million during Q1 2015.
  • In the last 3 years, EyePoint Pharmaceuticals' Total Current Liabilities had a median value of $21.2 million in 2018 and averaged $14.5 million.
  • Per our database at Business Quant, EyePoint Pharmaceuticals' Total Current Liabilities declined by 13.74% in 2017 and then spiked by 423.91% in 2018.
  • Quarterly analysis of 5 years shows EyePoint Pharmaceuticals' Total Current Liabilities stood at $3.9 million in 2015, then increased by 26.89% to $4.9 million in 2016, then declined by 13.74% to $4.2 million in 2017, then skyrocketed by 404.92% to $21.5 million in 2018, then climbed by 16.23% to $24.7 million in 2019.
  • Its last three reported values are $24.7 million in Q1 2019, $21.5 million for Q4 2018, and $22.4 million during Q3 2018.